Sofinno­va Part­ners lands €165M, backed by big phar­ma, to build ear­ly-stage biotechs in Eu­rope

Eu­ro­pean life sci­ences in­vestor Sofinno­va Part­ners dis­closed a €165 mil­lion ac­cel­er­a­tion fund on Tues­day to back ear­ly-stage sci­ence in Italy, France, the Unit­ed King­dom and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.